We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.56B
AUM Growth
+$94.2M
(+1.7%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
4,002
New
390
Increased
2,050
Reduced
771
Closed
169
Avg Time Held Equity + Options
4.8
years
Top 10 Avg Time Held Equity + Options
3.5
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
4.8
years
Top 10 Avg Time Held Equity only
3.5
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$160M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$59.5M |
| 3 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$57M |
| 4 |
JPMorgan International Bond Opportunities ETF
JPIB
|
+$43M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$180M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$51M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.59M |
| 4 |
CVB Financial
CVBF
|
+$3.2M |
| 5 |
iShares International Select Dividend ETF
IDV
|
+$3.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.36% |
| 2 | Technology | 16.32% |
| 3 | Healthcare | 6.92% |
| 4 | Financials | 6.46% |
| 5 | Communication Services | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
Barclays
BCS
$77.4B
| $460K | 0.01% |
21,743
+2,040
| +10% | +$49.7K |
2016 Q4
37 quarters
|
|
752
AB InBev
BUD
$163B
| $460K | 0.01% |
6,626
+708
| +12% | +$51.1K |
2016 Q4
37 quarters
|
|
753
Takeda Pharmaceutical
TAK
$62.6B
| $457K | 0.01% |
24,651
+2,343
| +11% | +$41.1K |
2019 Q1
28 quarters
|
|
754
Viking Therapeutics
VKTX
$3.38B
| $456K | 0.01% |
14,020
+3,447
| +33% | +$111K |
2024 Q3
6 quarters
|
|
755
OneMain Financial
OMF
$6.53B
| $456K | 0.01% |
8,522
+49
| +0.6% | +$2.91K |
2018 Q4
29 quarters
|
|
756
lululemon athletica
LULU
$11.5B
| $456K | 0.01% |
2,976
-429
| -13% | -$76.9K |
2016 Q4
37 quarters
|
|
757
Amdocs
DOX
$6.32B
| $456K | 0.01% |
6,980
-870
| -11% | -$63.6K |
2016 Q4
37 quarters
|
|
758
CF Industries
CF
$18.1B
| $450K | 0.01% |
3,466
+501
| +17% | +$51.1K |
2016 Q4
37 quarters
|
|
759
Prudential Financial
PRU
$40.1B
| $449K | 0.01% |
4,598
+409
| +10% | +$42.4K |
2016 Q4
37 quarters
|
|
760
Cincinnati Financial
CINF
$26B
| $449K | 0.01% |
2,853
-23
| -0.8% | -$3.74K |
2016 Q4
37 quarters
|
|
761
Expedia Group
EXPE
$35.5B
| $445K | 0.01% |
1,927
+67
| +4% | +$16.5K |
2016 Q4
37 quarters
|
|
762
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $445K | 0.01% |
10,513
+2,331
| +28% | +$99.5K |
2019 Q3
26 quarters
|
|
763
Mettler-Toledo International
MTD
$32.9B
| $445K | 0.01% |
352
+22
| +7% | +$29.7K |
2016 Q4
37 quarters
|
|
764
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.31B
| $443K | 0.01% |
+2,877
| New | +$464K |
2026 Q1
0 quarters
|
|
765
BlackRock MuniYield Michigan Quality Fund
MIY
$339M
| $443K | 0.01% |
+37,318
| New | +$455K |
2026 Q1
0 quarters
|
|
766
Okta
OKTA
$33.5B
| $442K | 0.01% |
5,611
+945
| +20% | +$78.4K |
2018 Q1
32 quarters
|
|
767
Strategy Inc
MSTR
$60.4B
| $440K | 0.01% |
3,521
+48
| +1% | +$6.86K |
2020 Q2
23 quarters
|
|
768
iShares 7-10 Year Treasury Bond ETF
IEF
$41.7B
| $439K | 0.01% |
4,594
-42
| -0.9% | -$4.04K |
2016 Q4
37 quarters
|
|
769
On Holding
ONON
$11.7B
| $438K | 0.01% |
12,887
+2,432
| +23% | +$106K |
2021 Q4
17 quarters
|
|
770
D.R. Horton
DHI
$39.4B
| $437K | 0.01% |
3,188
+45
| +1% | +$6.8K |
2016 Q4
37 quarters
|
|
771
Celestica
CLS
$38.8B
| $437K | 0.01% |
1,552
-69
| -4% | -$20K |
2020 Q1
24 quarters
|
|
772
VICI Properties
VICI
$26B
| $437K | 0.01% |
16,009
+5,315
| +50% | +$152K |
2018 Q2
31 quarters
|
|
773
Krystal Biotech
KRYS
$9.58B
| $436K | 0.01% |
1,688
+8
| +0.5% | +$2.13K |
2020 Q2
23 quarters
|
|
774
DELISTED
Hologic
HOLX
| $434K | 0.01% |
5,743
+2,131
| +59% | +$160K |
2016 Q4
37 quarters
|
|
775
Sysco
SYY
$40.5B
| $432K | 0.01% |
6,060
+568
| +10% | +$47K |
2016 Q4
37 quarters
|
|
Similar funds
Parallel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $293M of net new capital in Q1 2026, opening 390 new positions and adding to 2,050 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.
- Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
- Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
- Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
- Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
- Parallel Advisors opened 390 new positions and closed 169 in Q1 2026.
- Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.